Related Experiment Videos
[For which liver diseases is immunosuppressive therapy indicated?]
Medizinische Klinik (Praxis-Ausg.)
|August 6, 1982
Summary
Immunosuppressive therapy is justified for patients with chronic hepatitis who do not improve with conservative treatment. This approach showed significant improvement rates across various chronic liver disease subtypes, including aggressive hepatitis and cirrhosis.
Area of Science:
- Hepatology
- Immunology
- Gastroenterology
Context:
- 464 cases of chronic hepatitis were analyzed.
- 271 patients experienced disease aggravation despite conservative treatment.
- Focus on determining the efficacy of immunosuppressive agents in specific chronic liver conditions.
Purpose:
- To evaluate the effectiveness of immunosuppressive therapy in chronic hepatitis.
- To identify specific chronic liver disease subtypes that benefit from immunosuppressive treatment.
- To provide evidence-based guidance on when to initiate immunosuppressive therapy.
Summary:
- Immunosuppressive therapy demonstrated varied success rates across different chronic hepatitis classifications.
- High improvement rates were observed in lupoid hepatitis (84%) and chronic aggressive hepatitis with strong activity (78%).
- Lower but notable improvements were seen in chronic persisting hepatitis (34%) and cirrhosis subtypes (57.9%-60%).
Impact:
- Provides critical data for clinicians regarding the judicious use of immunosuppressive agents in chronic liver disease.
- Highlights the differential response to immunosuppression based on hepatitis subtype and activity.
- Contributes to optimizing treatment strategies for chronic hepatitis, potentially improving patient outcomes.